A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.
Clinical trial NCT00843687 · COMPLETED
Trial details
- NCT number
- NCT00843687
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-03-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.